- Identify the clinical features and diagnostic challenges of familial chylomicronemia syndrome (FCS) to prevent serious complications such as acute pancreatitis.
- Evaluate the limitations of conventional triglyceride-lowering therapies and examine the potential of emerging treatments targeting apolipoprotein C-III.
Familial Chylomicronemia Syndrome: Advancing Early Diagnosis and Targeted Treatment Strategies
Wednesday, July 16, 2025
8:00 - 9:30 PM EDT
VIRTUAL
OVERVIEW
HCPLive® Clinical Forum are regional roundtable discussions where an expert moderator has the opportunity to directly engage with community health care professionals (HCPs) to present data, medical advances, and patient case scenarios. This leads to a moderated forum between attendees to gather insights on their community practice implementation of new science, feedback on case scenarios, as well as other information which impact the clinical decision making of local HCPs.
These forums serve as a platform for localized education and peer-to-peer collaborative discussions aiming to ultimately elevate and improve patient care.
LEARNING OBJECTIVES
MARKET RESEARCH PARTICIPATION
This event is held in partnership with Healthcare Research & Analytics® to gain market research insights into health care professional’s educational needs in their current practice setting.
HR&A offers compensation of $1000 to physicians for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.
Copyright HCPLive 2025.
All Rights Reserved.
Privacy Policy
Contact Us: events@hcplive.com